J Food Bioact
US$ 26.61
bpc-157 human clinical trial The Real Story: 544 Papers, 30 Subjects, 50 Million Views BPC-157: What you need to
Description
Importantly, unlike HGH, AOD9604 doesnt meaningfully raise IGF1 levels, meaning its effects on muscle growth and recovery are minimal (human safety data)
We include it on PDP because the research community treats it as a peptide-adjacent metabolic tool and frequently compares it to peptides like MOTS-c and AOD-9604
However, human safety data remains limited to anecdotal reports and Phase I/II trial abstracts that never reached full peer-reviewed publication
Thats a rare dataset for a research peptide
